Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Sam McNeil / AP
A Stanford professor and heart surgeon has completed a proof-of-concept study showcasing the potential for photosynthetic cyanobacteria to treat the complications of heart attacks, per Smithsonian Magazine.
The traditional treatment: During a heart attack, heart tissue rapidly stops receiving blood containing oxygen and nutrients, which can lead to severe heart failure and death. So doctors try to get blood to the heart as soon as possible in order to provide critical oxygen and sugars.
The novel solution: The Stanford team injected a lab-grown strain of cyanobacteria — tiny photosynthetic organisms that use sunlight to convert carbon dioxide and water into oxygen and sugars — into a rat's heart and turned on a light. They saw increased metabolism within 20 minutes and improved heart performance in under an hour.
The drawbacks: Right now, the process requires open-heart surgery for the injection of cyanobacteria and the application of light. Additionally, the costs of outfitting hospitals with the equipment necessary for such a time-sensitive procedure might prove difficult.